HRS: Subcutaneous Defibrillators Are Effective

Subcutaneous implantable cardioverter offers viable alternative to standard defibrillator

THURSDAY, May 5 (HealthDay News) -- A new minimally invasive subcutaneous implantable cardioverter defibrillator (S-ICD) system is an acceptable alternative to conventional implantable cardiac defibrillators (ICDs), according to a study presented at the Heart Rhythm Society's Annual Scientific Sessions, held from May 4 to 7 in San Francisco.

Lara Dabiri Abkenari, M.D., from the Erasmus Medical Center in the Netherlands, and colleagues described the initial clinical experience with a new S-ICD system. S-ICDs were implanted without fluoroscopy, according to guidelines, in 98 patients with cardiac disease such as ischemic cardiomyopathy (40 patients), non-ischemic dilated cardiomyopathy, Brugada syndrome, and idiopathic ventricular fibrillation (VF). A primary prevention indication was present in 62 patients. Defibrillation efficacy was tested after implantation using 65 J shocks. Patients were followed up for an average of nine months.

The investigators found that the S-ICD system accurately detected and successfully converted all episodes of induced VF through appropriate shock. The S-ICD system accurately detected 34 spontaneous ventricular arrhythmias (sustained and non-sustained) in six patients, and effectively treated 23 arrhythmic episodes in three patients. Eight patients experienced inappropriate therapy due to oversensing but a software upgrade prevented recurrence of inappropriate therapy.

"All episodes of VF were accurately detected, and successfully converted. No sudden death occurred. In our experience, the S-ICD system is a viable alternative to conventional ICD systems for selected patients," the authors write.

Press Release
More Information

Physician’s Briefing Staff

Physician’s Briefing Staff

Published on May 05, 2011

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ